CanSino Biologics Inc is a CN-based company operating in Biotechnology industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,105 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a China-based company primarily engaged in the research and development, production, and commercialization of human vaccine products. The Company’s products and product pipeline under research include multiple vaccine varieties such as meningitis, pneumonia, diphtheria, tetanus, and pertussis (DPT), coronavirus disease 2019 (COVID-19), Ebola virus disease, poliomyelitis, herpes zoster, tuberculosis and others. The firm is also engaged in the research and development of pharmaceutical production processes. The firm conducts its business in the domestic and overseas markets.
06185.HK stock price ended at $37.38 on 金曜日, after dropping 0.53%
On the latest trading day Jan 16, 2026, the stock price of 06185.HK fell by 0.53%, dropping from $37.60 to $37.38. During the session, the stock saw a volatility of 3.27%, with prices oscillating between a daily low of $36.70 and a high of $37.90. On the latest trading day, the trading volume for 06185.HK rose by 260.6K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 914.8K shares were traded, with a market value of approximately $4.9B.